Roche Makes Unsolicited Bid to Buy Ventana for $3B; Ventana Urges Nonaction | GenomeWeb
NEW YORK (GenomeWeb News) — Roche yesterday made an unsolicited bid to buy Ventana Medical Systems for around $3 billion, or $75 per share, 45 percent higher than Ventana’s closing price yesterday of $51.74.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.